ID   X3CL1_RAT               Reviewed;         393 AA.
AC   O55145;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   14-AUG-2001, sequence version 3.
DT   24-JUL-2024, entry version 146.
DE   RecName: Full=Fractalkine;
DE   AltName: Full=C-X3-C motif chemokine 1;
DE   AltName: Full=CX3C membrane-anchored chemokine;
DE   AltName: Full=Neurotactin;
DE   AltName: Full=Small-inducible cytokine D1;
DE   Contains:
DE     RecName: Full=Processed fractalkine;
DE   Flags: Precursor;
GN   Name=Cx3cl1; Synonyms=Acc1, Fkn, Scyd1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9724801; DOI=10.1073/pnas.95.18.10896;
RA   Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K.,
RA   Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P.,
RA   Bacon K.B., Feng L.;
RT   "Role for neuronally derived fractalkine in mediating interactions between
RT   neurons and CX3CR1-expressing microglia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10896-10901(1998).
RN   [2]
RP   SEQUENCE REVISION TO 127-151.
RA   Feng L., Harrison J.K.;
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 204-335, AND TISSUE SPECIFICITY.
RX   PubMed=9845323; DOI=10.1016/s0014-5793(98)01384-2;
RA   Schwaeble W.J., Stover C.M., Schall T.J., Dairaghi D.J., Trinder P.K.E.,
RA   Linington C., Iglesias A., Schubart A., Lynch N.J., Weihe E.,
RA   Schaefer M.K.-H.;
RT   "Neuronal expression of fractalkine in the presence and absence of
RT   inflammation.";
RL   FEBS Lett. 439:203-207(1998).
CC   -!- FUNCTION: Chemokine that acts as a ligand for both CX3CR1 and integrins
CC       ITGAV:ITGB3 and ITGA4:ITGB1. The CX3CR1-CX3CL1 signaling exerts
CC       distinct functions in different tissue compartments, such as immune
CC       response, inflammation, cell adhesion and chemotaxis. Regulates
CC       leukocyte adhesion and migration processes at the endothelium. Can
CC       activate integrins in both a CX3CR1-dependent and CX3CR1-independent
CC       manner. In the presence of CX3CR1, activates integrins by binding to
CC       the classical ligand-binding site (site 1) in integrins. In the absence
CC       of CX3CR1, binds to a second site (site 2) in integrins which is
CC       distinct from site 1 and enhances the binding of other integrin ligands
CC       to site 1. {ECO:0000250|UniProtKB:P78423}.
CC   -!- FUNCTION: [Processed fractalkine]: The soluble form is chemotactic for
CC       T-cells and monocytes, but not for neutrophils.
CC       {ECO:0000250|UniProtKB:P78423}.
CC   -!- FUNCTION: [Fractalkine]: The membrane-bound form promotes adhesion of
CC       those leukocytes to endothelial cells. {ECO:0000250|UniProtKB:P78423}.
CC   -!- SUBUNIT: Monomer. Forms a ternary complex with CX3CR1 and ITGAV:ITGB3
CC       or ITGA4:ITGB1. {ECO:0000250|UniProtKB:P78423}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P78423};
CC       Single-pass type I membrane protein {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Processed fractalkine]: Secreted
CC       {ECO:0000250|UniProtKB:P78423}.
CC   -!- TISSUE SPECIFICITY: Highest levels in brain (neurons). Significant
CC       levels in kidney, heart, lung and adrenal gland.
CC       {ECO:0000269|PubMed:9724801, ECO:0000269|PubMed:9845323}.
CC   -!- PTM: A soluble short form may be released by proteolytic cleavage from
CC       the long membrane-anchored form. {ECO:0000250|UniProtKB:P78423}.
CC   -!- SIMILARITY: Belongs to the intercrine delta family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF030358; AAC33834.2; -; mRNA.
DR   EMBL; Y16813; CAA76404.1; -; mRNA.
DR   RefSeq; NP_604450.1; NM_134455.1.
DR   AlphaFoldDB; O55145; -.
DR   SMR; O55145; -.
DR   BioGRID; 250131; 1.
DR   STRING; 10116.ENSRNOP00000022128; -.
DR   GlyCosmos; O55145; 1 site, No reported glycans.
DR   GlyGen; O55145; 1 site.
DR   PhosphoSitePlus; O55145; -.
DR   SwissPalm; O55145; -.
DR   PaxDb; 10116-ENSRNOP00000022128; -.
DR   GeneID; 89808; -.
DR   KEGG; rno:89808; -.
DR   UCSC; RGD:620458; rat.
DR   AGR; RGD:620458; -.
DR   CTD; 6376; -.
DR   RGD; 620458; Cx3cl1.
DR   eggNOG; ENOG502SNIE; Eukaryota.
DR   InParanoid; O55145; -.
DR   OrthoDB; 5324229at2759; -.
DR   PhylomeDB; O55145; -.
DR   Reactome; R-RNO-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:O55145; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:ARUK-UCL.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IDA:ARUK-UCL.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:ARUK-UCL.
DR   GO; GO:0043005; C:neuron projection; IDA:ARUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:ARUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0048020; F:CCR chemokine receptor binding; IBA:GO_Central.
DR   GO; GO:0042056; F:chemoattractant activity; ISO:RGD.
DR   GO; GO:0008009; F:chemokine activity; IDA:RGD.
DR   GO; GO:0031737; F:CX3C chemokine receptor binding; ISS:UniProtKB.
DR   GO; GO:0045237; F:CXCR1 chemokine receptor binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR   GO; GO:0060055; P:angiogenesis involved in wound healing; ISO:RGD.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IBA:GO_Central.
DR   GO; GO:0035425; P:autocrine signaling; IGI:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; ISO:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IDA:ARUK-UCL.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IDA:ARUK-UCL.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0006935; P:chemotaxis; IDA:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0048245; P:eosinophil chemotaxis; IBA:GO_Central.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; IMP:RGD.
DR   GO; GO:0033622; P:integrin activation; ISS:UniProtKB.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0048247; P:lymphocyte chemotaxis; ISO:RGD.
DR   GO; GO:0001774; P:microglial cell activation; IDA:ARUK-UCL.
DR   GO; GO:0061518; P:microglial cell proliferation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:1900450; P:negative regulation of glutamate receptor signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0110091; P:negative regulation of hippocampal neuron apoptotic process; ISO:RGD.
DR   GO; GO:0032690; P:negative regulation of interleukin-1 alpha production; IDA:ARUK-UCL.
DR   GO; GO:1903979; P:negative regulation of microglial cell activation; IDA:ARUK-UCL.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0045906; P:negative regulation of vasoconstriction; IDA:RGD.
DR   GO; GO:0070050; P:neuron cellular homeostasis; IDA:ARUK-UCL.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISO:RGD.
DR   GO; GO:0050918; P:positive chemotaxis; ISO:RGD.
DR   GO; GO:0032233; P:positive regulation of actin filament bundle assembly; ISO:RGD.
DR   GO; GO:0051041; P:positive regulation of calcium-independent cell-cell adhesion; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; IGI:ARUK-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:1903721; P:positive regulation of I-kappaB phosphorylation; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; IMP:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:1904141; P:positive regulation of microglial cell migration; ISO:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IDA:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:ARUK-UCL.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:ARUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:ARUK-UCL.
DR   GO; GO:0032914; P:positive regulation of transforming growth factor beta1 production; ISO:RGD.
DR   GO; GO:0031664; P:regulation of lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IGI:ARUK-UCL.
DR   GO; GO:0042060; P:wound healing; ISO:RGD.
DR   CDD; cd00274; Chemokine_CX3C; 1.
DR   Gene3D; 2.40.50.40; -; 1.
DR   InterPro; IPR039809; Chemokine_b/g/d.
DR   InterPro; IPR034127; Chemokine_CX3C.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   InterPro; IPR036048; Interleukin_8-like_sf.
DR   PANTHER; PTHR12015:SF92; FRACTALKINE; 1.
DR   PANTHER; PTHR12015; SMALL INDUCIBLE CYTOKINE A; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR01721; FRACTALKINE.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; Interleukin 8-like chemokines; 1.
PE   2: Evidence at transcript level;
KW   Cell adhesion; Cell membrane; Chemotaxis; Cytokine; Disulfide bond;
KW   Glycoprotein; Inflammatory response; Membrane; Reference proteome;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..393
FT                   /note="Fractalkine"
FT                   /id="PRO_0000005254"
FT   CHAIN           25..?335
FT                   /note="Processed fractalkine"
FT                   /id="PRO_0000296226"
FT   TOPO_DOM        25..337
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        338..358
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        359..393
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          25..100
FT                   /note="Chemokine and involved in interaction with
FT                   ITGAV:ITGB3 and ITGA4:ITGB1"
FT                   /evidence="ECO:0000250|UniProtKB:P78423"
FT   REGION          101..337
FT                   /note="Mucin-like stalk"
FT   REGION          114..184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          213..303
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        148..177
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        213..259
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        281..299
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            335..336
FT                   /note="Cleavage; to produce soluble form"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        33
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        32..58
FT                   /evidence="ECO:0000250|UniProtKB:P78423"
FT   DISULFID        36..74
FT                   /evidence="ECO:0000250|UniProtKB:P78423"
SQ   SEQUENCE   393 AA;  41977 MW;  F06BB027CBD8CE14 CRC64;
     MAPSQLAWLL RLAAFFHLCT LLAGQHLGMT KCNITCHKMT SPIPVTLLIH YQLNQESCGK
     RAIILETRQH RHFCADPKEK WVQDAMKHLD HQTAALTRNG GKFEKRVDNV TPRITSATRG
     LSPTALAKPE SATVEDLTLE PTAISQEARR PMGTSQEPPA AVTGSSPSTS KAQDAGLAAK
     PQSTGISEVA AVSTTIWPSS AVYQSGSSLW AEEKATESPP TIALSTQAST TSSPKQNVGS
     EGQPPWVQEQ DSTPEKSPGP EETNPVHTDI FQDRGPGSTV HPSVAPTSSE KTPSPELVAS
     GSQAPKVEEP IHATADPQKL SVFITPVPDS QAATRRQAVG LLAFLGLLFC LGVAMFAYQS
     LQGCPRKMAG EMVEGLRYVP RSCGSNSYVL VPV
//
